Autor: "Andrake MD" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.
Autorzy:: Demidova EV; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.; Kazan Federal University, Kazan, 420008, Russia.
Serebriiskii IG; Kazan Federal University, Kazan, 420008, Russia.; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Vlasenkova R; Kazan Federal University, Kazan, 420008, Russia.; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Kelow S; Department of Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Andrake MD; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Hartman TR; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.; Arcadia University, Glenside, PA, USA.
Kent T; Department of Biochemistry & Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jeferson University, Philadelphia, PA, 19107, USA.
Virtucio J; Ecological and Evolutionary Signal-Processing and Informatics Laboratory, Department of Electrical and Computer Engineering, College of Engineering, Drexel University, Philadelphia, PA, 19104, USA.
Rosen GL; Ecological and Evolutionary Signal-Processing and Informatics Laboratory, Department of Electrical and Computer Engineering, College of Engineering, Drexel University, Philadelphia, PA, 19104, USA.
Pomerantz RT; Department of Biochemistry & Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jeferson University, Philadelphia, PA, 19107, USA.
Dunbrack RL Jr; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Golemis EA; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.; Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA.
Hall MJ; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.; Department of Clinical Genetics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
Chen DYT; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Daly MB; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. .; Department of Clinical Genetics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. .
Arora S; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. .; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2023 Jul 10; Vol. 24 (1), pp. 388. Date of Electronic Publication: 2023 Jul 10.
Typ publikacji:: Published Erratum

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.
Autorzy:: Demidova EV; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.; Kazan Federal University, Kazan, 420008, Russia.
Serebriiskii IG; Kazan Federal University, Kazan, 420008, Russia.; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Vlasenkova R; Kazan Federal University, Kazan, 420008, Russia.; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Kelow S; Department of Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Andrake MD; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Hartman TR; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.; Arcadia University, Glenside, PA, USA.
Kent T; Department of Biochemistry & Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Virtucio J; Ecological and Evolutionary Signal-Processing and Informatics Laboratory, Department of Electrical and Computer Engineering, College of Engineering, Drexel University, Philadelphia, PA, 19104, USA.
Rosen GL; Ecological and Evolutionary Signal-Processing and Informatics Laboratory, Department of Electrical and Computer Engineering, College of Engineering, Drexel University, Philadelphia, PA, 19104, USA.
Pomerantz RT; Department of Biochemistry & Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Dunbrack RL Jr; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Golemis EA; Program in Cancer Signaling and Microenvironment, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.; Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA.
Hall MJ; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.; Department of Clinical Genetics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
Chen DYT; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA.
Daly MB; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. .; Department of Clinical Genetics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. .
Arora S; Cancer Prevention and Control Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. .; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2023 Apr 24; Vol. 24 (1), pp. 212. Date of Electronic Publication: 2023 Apr 24.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Renal Cell*
Kidney Neoplasms*
Humans ; Genetic Predisposition to Disease ; DNA Replication ; Germ-Line Mutation ; Germ Cells

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.
Autorzy:: Kueppers F; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. .
Andrake MD; Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Xu Q; Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Dunbrack RL Jr; Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Kim J; Biocerna LLC, Fulton, Maryland, USA.
Sanders CL; Biocerna LLC, Fulton, Maryland, USA.; Pokaż więcej
Źródło:: BMC medical genetics [BMC Med Genet] 2019 Jul 15; Vol. 20 (1), pp. 125. Date of Electronic Publication: 2019 Jul 15.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Genetic Variation*
Models, Molecular*
alpha 1-Antitrypsin/*chemistry
alpha 1-Antitrypsin/*genetics
alpha 1-Antitrypsin Deficiency/*genetics
Adult ; Aged ; Aged, 80 and over ; Amino Acid Substitution ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Middle Aged ; Pennsylvania ; Protein Conformation, alpha-Helical ; RNA Splicing ; Sequence Analysis, Protein ; Virulence/genetics ; alpha 1-Antitrypsin/blood ; alpha 1-Antitrypsin Deficiency/diagnosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Comparison of metal-dependent catalysis by HIV-1 and ASV integrase proteins using a new and rapid, moderate throughput assay for joining activity in solution.
Autorzy:: Andrake MD; Institute for Cancer Research, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Ramcharan J; Locus Pharmaceuticals, Inc, Blue Bell, PA, USA.
Merkel G; Institute for Cancer Research, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Zhao XZ; Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
Burke TR Jr; Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
Skalka AM; Institute for Cancer Research, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.; Pokaż więcej
Źródło:: AIDS research and therapy [AIDS Res Ther] 2009 Jun 29; Vol. 6, pp. 14. Date of Electronic Publication: 2009 Jun 29.
Typ publikacji:: Journal Article